Lincluden Management Ltd. Has $2 Million Holdings in Johnson & Johnson $JNJ

Lincluden Management Ltd. cut its stake in Johnson & Johnson (NYSE:JNJ) by 2.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,098 shares of the company’s stock after selling 269 shares during the period. Lincluden Management Ltd.’s holdings in Johnson & Johnson were worth $2,001,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Sather Financial Group Inc boosted its stake in shares of Johnson & Johnson by 108.9% during the 2nd quarter. Sather Financial Group Inc now owns 5,756 shares of the company’s stock worth $879,000 after buying an additional 3,000 shares during the last quarter. Sovereign Financial Group Inc. grew its holdings in shares of Johnson & Johnson by 3.0% in the 2nd quarter. Sovereign Financial Group Inc. now owns 4,045 shares of the company’s stock valued at $618,000 after acquiring an additional 117 shares in the last quarter. Concurrent Investment Advisors LLC grew its holdings in shares of Johnson & Johnson by 8.6% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 122,127 shares of the company’s stock valued at $18,655,000 after acquiring an additional 9,700 shares in the last quarter. waypoint wealth counsel grew its holdings in shares of Johnson & Johnson by 6.8% in the 2nd quarter. waypoint wealth counsel now owns 6,417 shares of the company’s stock valued at $980,000 after acquiring an additional 411 shares in the last quarter. Finally, Investment Advisory Group LLC grew its holdings in shares of Johnson & Johnson by 3.8% in the 2nd quarter. Investment Advisory Group LLC now owns 4,957 shares of the company’s stock valued at $757,000 after acquiring an additional 180 shares in the last quarter. 69.55% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Johnson & Johnson news, EVP Jennifer L. Taubert sold 56,471 shares of the stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $177.81, for a total value of $10,041,108.51. Following the transaction, the executive vice president directly owned 178,013 shares of the company’s stock, valued at $31,652,491.53. This represents a 24.08% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.16% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

JNJ has been the subject of several analyst reports. UBS Group set a $198.00 price objective on Johnson & Johnson in a report on Friday, October 3rd. Wall Street Zen upgraded Johnson & Johnson from a “hold” rating to a “buy” rating in a report on Saturday, September 13th. Erste Group Bank raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating in a report on Wednesday, July 23rd. Sanford C. Bernstein upped their target price on shares of Johnson & Johnson from $172.00 to $193.00 and gave the company a “market perform” rating in a report on Monday, October 6th. Finally, Weiss Ratings raised shares of Johnson & Johnson from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, Johnson & Johnson presently has a consensus rating of “Moderate Buy” and a consensus price target of $192.94.

Johnson & Johnson Stock Up 0.1%

Johnson & Johnson stock opened at $190.88 on Tuesday. The stock has a market cap of $459.71 billion, a P/E ratio of 20.42, a P/E/G ratio of 2.40 and a beta of 0.40. The company has a quick ratio of 0.76, a current ratio of 1.01 and a debt-to-equity ratio of 0.50. Johnson & Johnson has a twelve month low of $140.68 and a twelve month high of $192.10. The company’s 50-day moving average price is $178.88 and its two-hundred day moving average price is $163.97.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings results on Wednesday, August 30th. The company reported $2.26 earnings per share for the quarter. The firm had revenue of $24.02 billion for the quarter. Johnson & Johnson had a net margin of 25.00% and a return on equity of 32.49%. As a group, analysts expect that Johnson & Johnson will post 10.58 EPS for the current year.

Johnson & Johnson Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 26th were issued a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend was Tuesday, August 26th. Johnson & Johnson’s dividend payout ratio is currently 55.61%.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.